TipRanks
Vertex Pharmaceuticals Incorporated Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh (BR:VRTX34)
:VRTX34
Brazil Market
VRTX34
Vertex Pharmaceuticals Incorporated Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh
RESEARCH TOOLSreports

Vertex Pharmaceuticals Incorporated Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh (VRTX34) Stock News & Sentiment

― Followers
Quantum BioPharma Ltd. (NASDAQ: QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial
Premium
TipRanks Newswire
Quantum BioPharma Ltd. (NASDAQ: QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial
7d ago
BBIO
KRYS
Goldman Sachs Reiterates Buy on Vertex as Inaxaplin Data De-Risk Outlook; $653 Price Target Reaffirmed
Premium
Ratings
Goldman Sachs Reiterates Buy on Vertex as Inaxaplin Data De-Risk Outlook; $653 Price Target Reaffirmed
20d ago
VRTX
Vertex Top Pick Affirmed as Inaxaplin Progress Supports Pipeline Upside; $672 Price Target Reiterated
Premium
Ratings
Vertex Top Pick Affirmed as Inaxaplin Progress Supports Pipeline Upside; $672 Price Target Reiterated
20d ago
VRTX
Vertex: Competitive Threat Eases, Pipeline Strength Supports Unchanged $600 Price Target and Buy Rating
Premium
Ratings
Vertex: Competitive Threat Eases, Pipeline Strength Supports Unchanged $600 Price Target and Buy Rating
2M ago
VRTX
Vertex: Strong Q2 Beat and Raised Revenue Outlook Underpin Buy Rating and Broadening Growth Beyond CF
Premium
Ratings
Vertex: Strong Q2 Beat and Raised Revenue Outlook Underpin Buy Rating and Broadening Growth Beyond CF
2M ago
VRTX
Vertex: Buy Rating Reaffirmed with Unchanged $585 Price Target on Strong CF Performance and Late-Stage Pipeline Upside
Premium
Ratings
Vertex: Buy Rating Reaffirmed with Unchanged $585 Price Target on Strong CF Performance and Late-Stage Pipeline Upside
2M ago
VRTX
Vertex: Solid CF Fundamentals and Early Pipeline Credit Drive Price Target Raise to $442, Hold Rating Maintained
Premium
Ratings
Vertex: Solid CF Fundamentals and Early Pipeline Credit Drive Price Target Raise to $442, Hold Rating Maintained
2M ago
VRTX
More BR:VRTX34 News >

VRTX34 News on the Web

BMO Capital Remains a Buy on Vertex Pharmaceuticals (VRTX)
TipRanks News
Bullish
Scotiabank Sticks to Its Buy Rating for Vertex Pharmaceuticals (VRTX)
TipRanks News
Bullish
Citi Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)
TipRanks News
Bullish
Vertex Pharmaceuticals resumed with an Overweight at Morgan Stanley
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
BR:VRTX34
Sector Average
Media Buzz
This Week6 articles
Weekly Average3.75 articles
News Sentiment
This Week100%
Sector Average89%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

FAQ

What is BR:VRTX34’s Media Buzz Sentiment?
6 articles about BR:VRTX34 were published this week. In an average week, 3.75 articles are published.
    What is BR:VRTX34’s weekly average amount of articles?
    In an average week, 3.75 articles about BR:VRTX34 are published.
      What is BR:VRTX34’s News Sentiment?
      100% of articles about BR:VRTX34 were positive this week, compared to its sector average of 89%.
        General Stocks that are Trending in the News
        RPDRapid7
        TERATera Yatirim Menkul Degerler AS
        R2PD34Rapid7 Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.083333 Sh
        T2TD34Trade Desk, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.01 Sh A
        T1AM34Atlassian Corp Shs A Unsponsored Brazilian Depository Receipt Repr 0.05 Sh A
        Showing the stocks with the most bullish news sentiment over the past week